1 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Oncotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Irinotecan, Leucovorin, 5-Fluorouracil, Docetaxel, Cisplatin, Leucovorin, 5-Fluorouracil - Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction | Phase 3 | Completed | Mario Negri Institute for Pharmacological Research | 1100 | 2005-02-01 | 2014-07-18 |
| Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer paclitaxel, antitumor drug screening assay - Breast Cancer | Phase 2 | Unknown | Oncotech | 100 | 1997-07-01 | 2013-12-19 |
Breast Neoplasms (1) · Breast Neoplasms, Male (1)
Cisplatin (1) · Docetaxel (1) · Drug Screening Assays, Antitumor (1) · Fluorouracil (1) · Irinotecan (1) · Leucovorin (1) · Paclitaxel (1)
Italy (1) · United States (1)
Emilio Bajetta, MD (1) · Rita S. Mehta, MD (1)